The Capacity to Return
Geroscience has converted aging from a chronological given into a set of measurable and potentially modifiable biological processes. The hallmarks of aging, methylation clocks, proteomic organ clocks, and cell-type-specific aging signatures now allow biological age to be estimated independently of the calendar. Two problems accompany this achievement. The first is epistemological: a measurable biomarker can quietly become the definition of the state it was built to estimate. The second is economic: longevity science is maturing inside a commercial ecosystem that rewards patentable molecules, proprietary assays, repeat testing, and the conversion of ordinary aging into a treatable anxiety.
Objective. To propose a clinical framework for longevity that integrates contemporary geroscience with the geriatric traditions of intrinsic capacity and physical resilience, and that names, with appropriate precision, the way commercial incentives shape which questions about aging become scientifically visible.
Discussion. I propose the term commercial epistemic distortion for the structural condition in which economic incentives influence which questions are funded, which endpoints are privileged, how results are disseminated, and which interventions achieve clinical prominence. The term is deliberately narrower than fraud and does not imply that industry-sponsored science is invalid. Against this background I propose Adaptive Longevity Medicine (ALM), whose central construct is adaptive coherence: the capacity of a person, understood as an integrated biological, psychological, and relational system, to absorb perturbation, coordinate a compensatory response, recover toward a prior or viable functional state, and preserve meaningful agency over time. ALM shifts the primary clinical measurement from state to recovery kinetics — what happens to the organism after it is disturbed, how fast it returns, how completely, and whether its systems return together. Nine domains are described, together with a four-level, deliberately non-proprietary Adaptive Coherence Profile and a falsifiable four-phase research program.
Conclusion. Healthy longevity is not a younger biomarker profile. It is the retained capacity to recover, function, relate, and pursue what one values. The organizing question of longevity medicine should therefore move from How old is this organism biologically? to When life disturbs the system, how much of this person comes back?